Biotech firm Odyssey valued at $899.9 million as shares rises in Nasdaq debut

🌐 marketscreener.com —
Biotech firm Odyssey valued at $899.9 million as shares rises in Nasdaq debut

AI Summary

Biotech firm Odyssey has achieved a valuation of $899.9 million after a successful debut on the Nasdaq exchange, indicating strong investor interest in the biotech sector. This follows their earlier announced IPO.

Markets AI & Tech biotech stock market Odyssey Nasdaq valuation investors

Read original source →